Coronavirus | Featured Stories

FDA gives full approval to Pfizer COVID-19 vaccine

In this photo taken Wednesday, May 19, 2010, a sign in front of the Pfizer research and manufacturing facility in Pearl River, N.Y. Pfizer announced Tuesday that it would layoff 1250 people at the plant by 2014. The company will retain one research division at the site, employing 1,000. (AP Photo/Mark Lennihan)

Pfizer’s coronavirus vaccine has been fully approved by the FDA as of Monday.

It’s the first COVID vaccine to be fully approved by regulators, and is an upgrade from the emergency use authorization.
Pfizer developed the shots in partnership with BioNTech, a German biotech company.
The Acting FDA Commissioner, Dr. Janet Woodcock, hailed the vaccine’s approval as a “milestone.”
The Pfizer-BioNTech vaccine has been given to millions of Americans under emergency use authorization since last December.
Individuals 12 and older are eligible to get the vaccine.

The FDA says the Pfizer vaccine will be marketed as “Comirnaty” for those who are 16 and older.
The emergency use authorization for the shots still applies when it’s given to kids between 12 and 15.
The same goes for immunocompromised individuals who get a third dose of the vaccine.